The overall objective of this proposal is to perform a first-in-human home trial of the Electronic Osseoanchored Prostheses for the Rehabilitation of Amputees (e-OPRA) implant system in individuals with transhumeral amputations who have had Targeted Muscle Reinnervation (TMR) surgery and use a pattern recognition-controlled myoelectric prosthesis. The purpose of the study is to capture preliminary safety and effectiveness information on the e-OPRA device when used with the prosthetic systems. The investigators expect that the e-OPRA implant system will be safe and provide clinically and statistically significant improvements in control and comfort. Specifically, the investigators hypothesize that the e-OPRA system will (1) allow for training of more functional prosthesis controllers, (2) provide more stable electromyographic (EMG) signals, reducing the need to recalibrate the prosthetic control system, and (3) be more comfortable, as it does not require a tethered arm-band to record surface EMG signals. Phase 1: Perform TMR and e-OPRA surgeries in 8 persons with transhumeral amputations. Phase 2: Perform a randomized cross-over study to compare the OPRA and e-OPRA system (without sensory feedback) in 8 transhumeral amputees who have received TMR. Phase 3: Perform a randomized cross-over study to compare the e-OPRA system with and without sensory feedback in 8 transhumeral amputees who have received TMR.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Safety related: Adverse Event reporting
Timeframe: Through study completion for each subject, on average 3 years.
Effectiveness related: EMG Signal to Noise Ratio Testing
Timeframe: Month 11, Month 13, Month 16, Month 19, Month 22
Effectiveness related: Somatosensory Mapping
Timeframe: Month 11, Month 13, Month 16, Month 19, Month 22
Effectiveness related: EMG Signal to Noise Ratio Testing
Timeframe: Month 13, Month 16, Month19, Month 22
Effectiveness related: Somatosensory Mapping
Timeframe: Month 13, Month 16, Month19, Month 22